Dr. Kira Sheinerman is the co-founder and CEO of DiamiR. She is also a Managing Director, Investment Banking at H.C. Wainwright where she works on financial and strategic transactions for growth biotech companies. Dr. Sheinerman serves on the Board of Directors of the Boyce Thompson Institute, an affiliate of Cornell University, and as the senior strategic consultant to Aptorum Group (NASDAQ: APM). From October 2015 through December 2018, Dr. Sheinerman served as the co-chair of Alzheimer’s Association Business Consortium. Dr. Sheinerman received her Ph.D. in Biomedical Sciences from Mount Sinai School of Medicine for her work on molecular mechanisms of Alzheimer’s disease. Dr. Sheinerman also holds an Honors MBA from the Zicklin School of Business, Baruch College/CUNY.
Speaking In
[Available On-Demand]
DiamiR is a privately held molecular diagnostics company developing blood-based solutions for early…